Conference Highlights

The unstoppable progress in technology and scientific knowledge is reshaping our industry. It is delivering novel treatments for patients and digitized monitoring tools for healthcare professionals; improved operational efficiency, less waste, and resource conservation for industry; and greater connectivity for risk-based regulation.

The ongoing evolution of the pharmaceutical industry, aimed at propelling the next generation of medicines requires the close collaboration with regulators, emphasizing innovation, partnership, and a continued dedication to addressing patient needs. This transformation holds the potential to guide significant advancements in the development and delivery of medicines, leading to improved healthcare outcomes for patients. The Regulatory, Compliance and Quality (RCQ) track planned for the 2024 ISPE Annual Meeting & Expo, taking place 13-16 October, in Orlando, Florida, USA. will feature industry and regulatory experts in a variety of topic areas.

Globally, there is an increase in approved advanced therapy medicinal products (ATMPs), with thousands of therapies currently in various stages of pre-clinical and clinical development.

The pharmaceutical industry stands at the cusp of a transformative era, where the integration of sustainability within the supply chain is not just a trend, but a necessity. The 2024 ISPE Annual Meeting & Expo is the perfect platform for professionals to converge, share insights, and drive this change. The Supply Chain Resiliency and Sustainability sessions are designed to provide attendees with a comprehensive understanding of the latest strategies, innovations, and regulatory insights to ensure a robust supply chain and practical approach to sustainability in the pharmaceutical industry.

As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased exponentially — all while maintaining, or preferably reducing, the cost of goods. This year’s Manufacturing, Quality Control (QC), and Operational Excellence content track aims to address some of the many components that go towards realizing those expectations.

Rise of the Machines 
It becomes clear that a topic has become mainstream when it crosses multiple Communities of Practice and areas of interest. In preparation for the 2024 ISPE Annual Meeting & Expo, the Digital Transformation track committee worked closely with multiple teams from other tracks on the topic of artificial intelligence/machine learning (AI/ML) to identify the best and most appropriate tracks and sessions to present. To ensure the best program possible, the track teams took extra care and attention to make sure it would be possible to attend all of the AI/ML sessions irrespective of track across the conference’s five tracks of concurrent education sessions.

The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP (Emerging Technology Program), and the European Medicines Agency (EMA) with the Quality Innovation Group (QIG). There are also ongoing collaborative initiatives such as Orbis, ACCESS, and the International Coalition of Medicines Regulatory Authorities (ICMRA) that exemplify the effort of health authorities to provide potentially faster access to medicines for patients around the world.

Building off the success of the 2023 ISPE Annual Meeting & Expo, the program committee has developed a robust workshop program, taking place Sunday, 13 October, which is based on the practical application of the ISPE Baseline Guide and ISPE Good Practice Guide (GPG) Series, covering the following key areas:

As the pharmaceutical landscape rapidly evolves, staying informed and connected with industry leaders is more crucial than ever. The 2024 ISPE Annual Meeting & Expo, 13-16 October in Orlando, Florida, USA and virtually offers a unique platform to gain insights, enhance your professional development, and network with the brightest minds in the field. This event is designed to empower seasoned experts as well as emerging leaders with the tools and knowledge needed to excel in today’s competitive environment.

As the global pharmaceutical industry continues to evolve, staying ahead of the curve is more crucial than ever. The 2024 ISPE Annual Meeting & Expo, set to take place from 13 - 16 October in Orlando, Florida, USA and virtually is the opportunity to connect, collaborate, and lead in this dynamic landscape. This year’s event promises to be the most impactful yet, offering an unparalleled platform for professionals at all levels to deepen their knowledge, expand their networks, and drive their careers forward.

The 2024 ISPE Annual Meeting & Expo is the pharmaceutical industry’s gateway to discovering the latest trends, technologies, and best practices shaping the future of pharmaceutical engineering. This year, 13-16 October in Orlando, Florida, USA, ISPE has curated a diverse selection of education tracks that cater to every aspect of the industry, ensuring attendees gain the knowledge and skills needed to excel in their respective roles. This event is for seasoned professionals as well as those just starting their careers—there’s something for everyone. Let’s delve into what’s in store.

The2024 ISPE Annual Meeting & Expo, taking place 13 – 16 October in Orlando, Florida, USA and virtually is set to be a landmark gathering for pharmaceutical engineering professionals. This year’s meeting is packed with workshops designed to equip industry experts with the latest tools and insights necessary to navigate the rapidly evolving landscape of pharmaceutical technology and compliance.

In the rapidly evolving pharmaceutical landscape, artificial intelligence (AI) has been hailed as having the potential to revolutionize everything from drug discovery to pharmaceutical manufacturing. As the industry seeks to further explore and invest in potential opportunities for improvement and growth with AI, pursuing a thoughtful and informed approach to AI strategy planning becomes paramount.

In the ever-evolving landscape of the pharmaceutical industry, staying ahead of the curve is not just an advantage—it's a necessity. With rapid advancements in technology, regulatory shifts, and emerging global challenges, professionals need a platform to learn, network, and innovate. This year's 2024 ISPE Annual Meeting & Expo, taking place 13 – 16 October in Orlando, Florida, USA, offers precisely that opportunit

The proliferation of digital tools available in the pharmaceutical industry, including artificial intelligence (AI) and machine learning (ML), is revolutionizing drug discovery and manufacturing processes.

The 2024 ISPE Annual Meeting & Expo, taking place 13 – 16 October in Orlando, Florida, USA, and virtually, stands out as a key event in the pharmaceutical industry. Known for its rich educational offerings, the annual event serves as a dynamic platform where professionals gather to explore the latest trends, technologies, and regulatory developments impacting pharmaceutical manufacturing, quality, and compliance.